The wound care market differs from many medical product markets because wound care is significantly a broad-based market.
Patients with chronic wounds are not typically admitted to care facilities during their entire course of treatment. Accordingly product utilization must be designed to allow for patient application.
Technologies which rely on complicated procedures will likely result in increased costs and lowered efficiency. Wound treatment products must be able to perform on various type of wounds in numerous care giver circumstances. Otherwise, the product has limited utility.
BioCore's easy - to - follow application protocols bridge the confusion gap created by competing products, increasing ease, product utilization and efficiency.
BioCore's Kollagen products have been utilized in the treatment of over thousands of wounds in the field, ranging across all wound types & application settings.
Patients with pressure ulcers, diabetic ulcers, and traumatic wounds represent a few of BioCore’s major market segments in India. Projections indicate that these patient populations will continue to increase rapidly in the 21st century. As the population grows and Indians live longer, there will be an increased demand for effective and affordable wound care.
wound management products offer health care providers a strong technological
foundation to meet growing patient needs. This overview provides a snapshot
of the current wound care market in India.
Furthermore, these positive results are obtained in a cost-effective manner, benefiting both the physician and the patient.
BioCore does have extensive clinical study
results relating to the efficacy of its Kollagen technology. In all of
the studies, BioCore's technology healed wounds in a quicker fashion than